arrow_back Trending Legislation
Share share

Mandatory Disclosure of Drug Cost Compensation in Employer Health Plans.

This bill mandates that companies managing prescription drug benefits (PBMs) and third-party administrators must disclose all direct and indirect compensation they receive. The goal is to bring transparency to drug costs and services within employer-sponsored health plans. This allows employers and employees to better evaluate the efficiency and fairness of their health plan management.
Key points
Requires PBMs and administrators to reveal all fees and commissions related to employer-sponsored health plans.
Increased financial transparency aims to help control drug costs and improve the management of employee health benefits.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third-party administration services.
Print number: S 1543
Sponsor: Sen. Marshall, Roger [R-KS]
Process start date: 2023-05-10
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Mandatory Disclosure of Drug Cost Compensation in Employer Health Plans.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 1543.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-05-10.

What are the main provisions?

Key points include:

  • Requires PBMs and administrators to reveal all fees and commissions related to employer-sponsored health plans.
  • Increased financial transparency aims to help control drug costs and improve the management of employee health benefits.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Marshall, Roger [R-KS].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of S 1543

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Labor